Presumptive identification of Candida spp. and other clinically important yeasts: usefulness of brilliance™ candida agar.;Identificación presuntiva de Candida spp. y de otras levaduras de importancia clínica: utilidad de Brilliance Candida Agar

Revista Iberoamericana de Micologia

Volumn 27, Issue 2, 2010, Pages 90-93

  Alfonso, Claudia ^a   López, Mónica ^b   Arechavala, Alicia ^c   Perrone, María del Carmen ^d   Guelfand, Liliana ^e   Bianchi, Mario ^c  

^a Hospital Santojanni Buenos Aires   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c HOSPITAL F J MUÑIZ   (Argentina)

^d Hospital Interzonal Dr Jose Penna   (Argentina)

^e HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

Author keywords

Brilliance Candida Agar; Candida spp.; CHROMagar; Chromogenic agar; Presumptive identification

Indexed keywords

AGAR MEDIUM; ARTICLE; CANDIDA; CONTROLLED STUDY; CULTURE TECHNIQUE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; INTERMETHOD COMPARISON; NONHUMAN; SPECIES DIFFERENCE;

AGAR; ARGENTINA; CANDIDA; CANDIDIASIS; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

CANDIDA; CANDIDA ALBICANS;

EID: 77952884201     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.riam.2010.01.008     Document Type: Article

References (22)

1. Acosta G., Arteta Z., Ballesté R., Cabrera M.J., Cambol A., Fernández N., et al. Evaluación del medio Cromógeno CHROMagar Candida™ para la identificación de levaduras de interés médico. Rev Med Urug 2005, 21:186-193.
2. Almirante B., Rodríguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005, 43:1829-1835. Barcelona Candidemia Project Study Group.
3. Campbell C.K., Holmes A.D., Davey K.G., Szekely A., Warnock D.W. Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1998, 17:367-368.
4. Carrillo-Muñoz A.J., Quindós G., Cárdenes C.D., Alonso Vargas R., Arévalo P., Brió S., et al. Evaluación del medio Chromalbicans Agar para la identificación presuntiva de Candida albicans. Rev Iberoam Micol 2001, 18:105-108.
5. Cooke V., Miles R.J., Price R.G., Midgley G., Khamri W., Richardson A.C. New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 2002, 68:3622-3627.
6. Davel G., Canteros C. y participantes del Programa Nacional de Control de Calidad en Micología. Situación de las Micosis en Argentina. Rev Argent Microbiol 2007, 39:28-33.
7. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999, 29:239-244.
8. Ellepola A.N.B., Morrison C.J. Laboratory diagnosis o invasive candidiasis. J Microbiol 2005, 43:S65-S84.
9. Eraso E., Sahand I.H., Villar-Vidal M., Marcos C., Moragues D., Madariaga L., et al. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol 2006, 44:611-615.
10. Freydiere A.M., Guinet R., Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001, 39:9-33.
11. Galván B., Mariscal F. Epidemiología de la candidemia en UCI. Rev Iberoam Micol 2006, 23:12-15.
12. Ghelardi E., Pichierri G., Castagna B., Barnini S., Tavanti A., Campa M. Efficacy of chromogenic Candida agar for isolation and presumptive identification of pathogenic yeast species. Clin Microbiol Infect 2007, 14:141-147.
13. Jitsuron S., Klamsini S., Pattararagron N. Milk medium for germ tube and chlamydoconidiae production by Candida. Mycopathologia 1993, 123:95-98.
14. Koehler A.P., Chu K.C., Honang E.T., Cheng A.F. Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999, 37:422-426.
15. Kramer M., Feinstein A. Clinical bioestatistics. The bioestatistic of concordance. Clin Pharmacol Ther 1981, 29:111-112.
16. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
17. Linares Sicilia M.J., Solis Cuesta F. Identificación de levaduras. Guía práctica de identificación y diagnóstico en micología clínica 2001, 1-18. Rev Iberoam Micol. J. Pemán, E. Martín-Mazuelos, M.C. Rubio Calvo (Eds.).
18. Odds F.C. Candida and Candidosis 1988, Bailliere Tindall, Londres. 2nd ed.
19. Pfaller M.A., Jones R., Doren G.V., Sader H.S., Hollis R.J., Messer S.A. International surveillance of bloodstream infection due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and south America for the SENTRY program. J Clin Microbiol 1998, 36:1886-1889. for the SENTRY participant group.
20. Pincus D.H., Orenga S., Chatellier S. Yeast identification past, present, and future methods. Med Mycol 2007, 45:97-102.
21. Pontón J., Ruíz Camps I. Tratado SEIMC de enfermedades infecciosas y microbiología clínica. Capítulo 60 2006, 617-624. Ed. Médica Panamericana. V. Ausina Ruíz, S. Moreno Guillen (Eds.).
22. Sanabria R., Samudio M., Fariña N., Laspina F., Ortellado de Canese J., Arbizu Ledesma G., et al. Identificación de especies de Candida aisladas de pacientes ambulatorios, hospitalizados e inmunocomprometidos en Paraguay. Mem Inst Investig Cienc Salud 2006, 4:45-49.